We determined the effect of hemolysis, lipemia, and bilirubinemia on clinical-chemical analytical results under standardized conditions, for serum specimens prepared by us. Our purpose was to assess results obtained with 22 commonly available analytical systems. The quantitative rating scheme described is derived from the observed interference(s) divided by the number of analytical methods evaluated. The combined ranking reveals which chemistry analyzers are least affected and which are most affected by the added substances. Generally, systems that incorporate physical barriers or protein-separation steps perform better than those without thin-film layers, glass-fiber barriers, or dialysis membranes. Among the "direct" analyzers, fewer interferences are seen if appropriate "blanking" wavelengths are used, especially if a "specimen blank" absorbance is used appropriately in the analytical system. Centrifugal analyzers tended to perform poorly, according to the criteria presented here.
about the interferences that affect that system. We have been collecting data on the effects of hemolysate, lipids, and bilirubin on analytical results from many of the newer instruments, to allow comparison with the more familiar systems evaluated earlier (6) . Here we report our findings on 22 analytical systems, and propose a quantitative rating scheme to facilitate comparison of interference-testing resuits from diverse analytical instruments.
Materials and Methods

Specimen Preparation
Serum was adulterated with hemolysate, lipids (as added Intralipid#{174}; KabiVitrum Inc., Alameda, CA 94501), or bilirubin, as described earlier (6). All hemolysates were prepared from the same donor's blood, and for preliminary analyses we used the Du Pont Automatic Clinical Analyzer to assure consistency throughout in the concentration of analytes and added interferents.
Specimens were kept frozen and protected from light, and the analyses reported here were performed within one month of preparation. Table 1 shows the analytical systems evaluated, along with the manufacturer or distributor of the equipment and reagents, and the laboratory or colleague supplying the data used for this report. Whenever possible, we obtained results from more than one instrument, with duplicate runs from each. If an option was available to us, analytical results from the latest version of instrument, computer program, or reagent formulation was selected for further evaluation. Table 1 shows the specific version of software or other modification for those instruments having more than one configuration.
Instruments Evaluated
Because the data-collection phase covered several years, some of the newest reagents or instrument modifications are not included in this study, but we intend to continue updating our data base to incorporate recent improvements.
Plotting and Calculations
After normalizing the data from each analytical run by calculating the percentage increase or decrease from the original result for the unadulterated serum, we plotted the interference lines in the format of "interferographs," as described previously (6). In addition, we assigned a numerical value to each interferograph line, depending on the zone in which it appeared. These superimposed zones, which are shown in Figure 1 , were allocated in a way that simplifies reporting on interferences and that clearly distinguishes between affected and non-affected analyses. Zone 1 is limited to those results that were within 3% of the result for unadulterated serum at all concentrations of added interferent. The designation of zone 2 (or -2) applies to any results that deviated from the unaffected value by more than 3% (or -3%) but equal to or less than 20% (or -20%). The minimum allowable deviation from the ideal to define zones Figure 1 reveals that the transition from zones5 through 7 (or -5 through -7) occurs at the junction where the analytical results were doubled (or became zero) at added interferent concentrations that were either 75%, 50%, or 25% of the maximum added interferent used to challenge the system. If the plot of analytical result vs interferent concentration was not linear, assignment was made to the zone with the greatest absolute value into which any part of that line fell. Table 2 shows the serum constituents assayed and the zones associated with each interferograph line after lipidlike material, bilirubin, or hemolysate was added. Only those lines that were complete (results available at all concentrations of added interferent) and consistent (similar results from multiple instruments, or replicate runs on the same instrument) are listed without superscripts.
Results
From these data, we calculated the interferent-specific interference ratios ("interferratios") associated with each of The interferratio is a derived value, the consequence of the slope of each interferograph line. Therefore it is not subject to rigorous statistical analysis unless multiple interferographs are evaluated for a specific type of analytical system. The usefulness of the interferratio arises from the fact that it permits a rank-orderedlisting of a variety of analytical systems to demonstrate their relative freedom from effects due to added interfering substances. Inspection of Table 2 will reveal those analytical methods that fall short of the perfect analytical system-i.e., one that would display absolute analytical specificity even in the presence of potentially interfering substances. Figure 3 depicts the overall ranking of the clinical chemistry systems we evaluated, according to the arithmetic average of the interferent-specific ratios given in Figure 2 .
Discussion
The effect of interfering substances on certain assays is highly variable and can be either instrument-or reagentrelated. For example, the effect of lipemia on creatinine assay results led to zone assignment ranging from -8 to 8 ( Table 2 Ranking of analytical instruments,according to the interferratios determined after the addition of Intralipid, bilirubin, or hemolysateto serum Analyzershsted together (separated by a comma) had identical calculated interierratios. Analyticalsystemsaredesignated by letter codes listedIn TableI other analyzers rely on changes in absorbance or reflectance after reaction with alkaline picrate. These systems are programmed to operate in a variety of endpoint and kinetic modes, and demonstrate a tremendous diversity of responses to interfering substances. In contrast, there is a relative lack of effect from added bilirubin on any of the total protein assays, all of which rely on a variant of the biuret reagent. A study of Table 2 to determine which assays are least affected by interfering substances should indicate directions for future method-and reagent-development efforts.
By delineating numerical zones superimposed on interferographs we are introducing a quantitative scheme to rank analytical instruments according to their freedom from problems with added interferents. An added feature of the superimposed zones is the ease with which interference effects can be reported, e.g., as a "zone 2," or a "zone -4" effect. The ranking system depends on a calculated ratio Specifically, in the case of the two Hitachi instruments, the newer and more highly ranked system (737) features a specimen blank for each analytical channel, an optional and less well-developed aspect of the earlier instrument (705) at the time our specimens were analyzed. Different ion-selective electrodes, and an improved mathematical model for calculation of alkaline phosphatase activities are also part of the newer system.
The proposed rating scheme is a model, which we believe allows a meaningful comparison of the various analytical systems offered for use in clinical laboratories. As this model is improved and our data base is enlarged to include information about the effects of hemoglobin, lipoproteins, conjugated bilirubin(s), and drugs or metabolites, some of the limitations inherent in this preliminary report will be removed. We invite cooperation in our effort to introduce a more quantitative approach to the study, testing, and reporting of interferences in diagnostic equipment.
Note added in proof: Since this report was submitted, we have evaluated an updated Hitachi 705, with reagents identical to those in use on the Hitachi 737. As a result of improvements in reagent formulations, the new Hitachi 705 interferratio is 1.93, ranking it slightly above the SMA analyzer (see Figure 3) .
